DrugJun 7, 2017
SCA Pharmaceuticals ceFAZolin sodium added to 100 mL 0.9% Sodium Chloride injectable, 2g recall — FDA D-0876-2017
Lack of assurance of sterility: Product bags leaking at seam.
Class IIFDA: TerminatedSCA Pharmaceuticals
June 2017 recalls — page 6
These records include useful source details for the selected month.
How to use this monthly recall archive
Use this page to compare the recalls reported during the month, then open an individual record for the exact reason, classification, company, remedy or distribution information available from the official source. Monthly counts are descriptive, not a safety rating.